3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer
Phase NA Terminated
6 enrolled
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Phase 2 Terminated
92 enrolled
TRI-LARC
Phase 1/2 Terminated
94 enrolled
INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Phase 1/2 Terminated
6 enrolled
DICE
Phase 2 Terminated
7 enrolled
PaTcH
Phase 2 Terminated
20 enrolled
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Phase 2 Terminated
1 enrolled 1 chart
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
Terminated
14 enrolled 10 charts
Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement
Phase 2 Terminated
3 enrolled 11 charts
MENTHE
Terminated
315 enrolled
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Phase 1/2 Terminated
21 enrolled
PersoMed-I
Phase 2 Terminated
20 enrolled
NEMO
Phase 2 Terminated
37 enrolled
Panthera
Phase 1 Terminated
2 enrolled
CharactHer. ICORG 12-09, V3
Terminated
130 enrolled
Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
Terminated
161 enrolled
Ovarian Reserve in Premenopausal Breast Cancer
Terminated
216 enrolled
Plasma Biomarkers C-RAC, ICORG 12-27, V1
Terminated
109 enrolled
Lithium
Phase 1 Terminated
2 enrolled
ALERT-lung
Phase 2 Terminated
14 enrolled 14 charts
IFM2014-01
Phase 2 Terminated
26 enrolled
Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT
Phase 1/2 Terminated
14 enrolled
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals
Terminated
50 enrolled
Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Phase 2 Terminated
6 enrolled 12 charts
Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging
Phase NA Terminated
4 enrolled
SPLENDOUR
Phase 3 Terminated
595 enrolled 18 charts
STEREO
Phase 2 Terminated
6 enrolled
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
Phase 3 Terminated
4 enrolled 5 charts
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
Phase 2 Terminated
18 enrolled
PARCT
Phase 2 Terminated
26 enrolled
NIMBLe
Phase 2 Terminated
4 enrolled 4 charts
MINDACTRelapse
Terminated
31 enrolled
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Phase 1 Terminated
8 enrolled
ACCeSs
Phase 2 Terminated
3 enrolled
Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab
Phase NA Terminated
1 enrolled 1 chart
REACH
Phase 2 Terminated
2 enrolled
Covimmunomm
Phase NA Terminated
139 enrolled
Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker
Phase 2 Terminated
9 enrolled 8 charts
Observation or Radical Treatment in Patients With Prostate Cancer
Phase NA Terminated
180 enrolled 9 charts
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Phase 3 Terminated
406 enrolled 14 charts
OPERA-PLRG10
Phase 2 Terminated
1 enrolled
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
Phase 3 Terminated
41 enrolled
DART
Phase 3 Terminated
48 enrolled
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Phase 3 Terminated
19 enrolled
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Phase 3 Terminated
355 enrolled 11 charts
Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
Phase 2 Terminated
59 enrolled 8 charts
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
Phase 2 Terminated
26 enrolled 11 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
Phase 2 Terminated
16 enrolled 5 charts
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
Phase 2 Terminated
4 enrolled 6 charts